Transient transfection of a synthetic hammerhead ribozyme targeted against human MGMT gene to cells in culture potentiates the genotoxicity of the alkylation damage induced by mitozolomide

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 2, 1999, Pages 125-133

  Citti, L ^a   Eckstein, F ^b   Capecchi, B ^a   Mariani, L ^a   Nevischi, S ^a   Poggi, A ^a   Rainaldi, G ^a  

^a CNR   (Italy)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; MESSENGER RNA; MITOZOLOMIDE; NUCLEASE; PHOSPHOROTHIOIC ACID DERIVATIVE; PYRIMIDINE NUCLEOSIDE; RIBOZYME; THYMIDINE; URIDINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHO CELL; DNA ALKYLATION; GENETIC TRANSFECTION; GENOTOXICITY; HUMAN; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ANIMALIA; BOVINAE;

EID: 0033035858     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.125     Document Type: Article

References (13)

1. BEIGELMAN, L., McSWIGGEN, J.A., DRAPER, K.G., GONZALEZ, C., JENSEN, K., KARPEISKY, A.M., MODAK, A.S., MATULIC-ADAMIC, J., DI RENZO, A.B., HAEBERLI, P., SWEEDLER, D., TRACZ, D., GRIMM, S., WINCOTT, F.E., THACKRAY, V.G., and USMAN, N. (1995). Chemical modifications of hammerhead ribozymes: Catalytic activity and nuclease resistance. J. Biol. Chem. 270, 25702-25708.
2. BENNETT, C.F., CHIANG, M.Y., CHAN, H., SHOEMAKER, J.E., and MIRABELLI, C.K. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023-1033.
3. BIRIKH, K.R., HEATON, P.A., and ECKSTEIN, F. (1997). The structure, function and application of the hammerhead ribozyme. Eur. J. Biochem. 245, 1-16.
4. BRAMLAGE, B., LUZI, E., and ECKSTEIN, F. (1998). Designing ribozymes for the inhibition of gene expression. TIBTECH 16, 434-438.
5. BRATTY, J., CHARTRAND, P., FERBEYRE, G., and CEDERGREN, R. (1993). THe hammerhead RNA domain, a model ribozyme. Biochem. Biophys. Acta 1216, 345-359.
6. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. CITTI, L., BOLDRINI, L., NEVISCHI, S., MARIANI, L., and RAINALDI, G. (1997). Quantitation of in vitro activity of synthetic trans-acting ribozymes using HPLC. Biotechniques 23, 898-903.
8. + transfected cells to mitozolomide. Carcinogenesis 17, 25-29.
9. + cells by administration of antimessenger oligonucleotide targeted against methylguanine-DNA methyltransferase gene (MGMT). Anticancer Res. 14, 2667-2672.
10. 6-methylguanine-DNA methyltransferase molecules escaped from inactivation. Mutat. Res. 14, 173-179.
11. SNYDER, D.S., WU, Y., WANG, J.J., SWIDERSKI, P., KAPLAN, B., and FORMA, S.J. (1993). Ribozyme mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood 82, 600-605.
12. THOMSON, J.B., TUSCHL, T., and ECKSTEIN, F. (1996). The hammerhead ribozyme. Nucleic Acids Mol. Biol. 10, 173-196.
13. USMAN, N., and STINCHCOMB, D.T. (1996). Design, synthesis, and function of therapeutic hammerhead ribozymes. Nucleic Acids Mol. Biol. 10, 243-264.